GRP
ACAD icon

Global Retirement Partners’s Acadia Pharmaceuticals ACAD Stock Holding History

Global Retirement Partners’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$63.9K Buy
+2,526
New +$55.6K ﹤0.01% 2358
2025
Q4 		$135K Buy
+5,051
New +$121K ﹤0.01% 1715
2024
Q4 		– Sell
-40
Closed -$615 – 3651
2024
Q3 		$615 Hold
40
– – ﹤0.01% 3238
2024
Q2 		$650 Buy
40
+15
+60% +$242 ﹤0.01% 3255
2024
Q1 		$462 Buy
+25
New +$619 ﹤0.01% 3147

Other funds holding ACAD

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Global Retirement Partners's ACAD Position: Q2 2026 in Review

Global Retirement Partners opened a new position in Acadia Pharmaceuticals (ACAD) in Q2 2026: 2,526 shares worth $63.9K. The stake represents ﹤0.01% of the portfolio and ranks #2358 among its holdings. This is a return to the name: Global Retirement Partners previously reported a position in ACAD as recently as Q4 2025.

Global Retirement Partners first reported a position in ACAD in Q1 2024 and has held it in 5 quarters since. The position peaked at $135K in Q4 2025. 354 funds tracked by Wall St. Rank hold ACAD as of Q2 2026.

  • Global Retirement Partners held 2,526 shares of Acadia Pharmaceuticals worth $63.9K as of Q2 2026.
  • Acadia Pharmaceuticals was a new Global Retirement Partners position in Q2 2026.
  • Acadia Pharmaceuticals made up ﹤0.01% of Global Retirement Partners's portfolio in Q2 2026, its #2358 holding.
  • Global Retirement Partners first reported a position in Acadia Pharmaceuticals in Q1 2024 and has held it in 5 quarters since.
  • Global Retirement Partners's Acadia Pharmaceuticals position peaked at $135K in Q4 2025.
  • 354 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q2 2026.

Based on Global Retirement Partners's 13F filing for Q2 2026, filed 6 Aug 2026.